Clinical Trials on Incipient Ovarian Failure

Total 16344 results

Xiaomei Shao
Hangzhou Hospital of Traditional Chinese Medicine

Recruiting

Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics

Diminished Ovarian Reserve

China
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

Ovarian PRP Injection in Women With POR

Poor Ovarian Response

China
Tongji Hospital

Not yet recruiting

A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve

Diminished Ovarian Reserve

China
Huazhong University of Science and Technology

Recruiting

Effect of Thumbtack Needle on Ovarian Function of Women With Diminished Ovarian Reserve (DOR)

Diminished Ovarian Reserve

China
Huazhong University of Science and Technology
Wuhan Union Hospital, China; Wuhan No.1 Hospital; The Affiliated Hospital of... and other collaborators

Recruiting

Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve

Diminished Ovarian Reserve

China
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Transplantation of hAMSCs for Woman With DOR

Diminished Ovarian Response

China
Centre Hospitalier Universitaire de Besancon
CHU de Reims; Central Hospital, Nancy, France; University Hospital, Bordeaux; University... and other collaborators

Recruiting

Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft (PERIDATOR)

Ovarian Function Insufficiency

France
Ferring Pharmaceuticals

Completed

Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice (NORSOS)

Controlled Ovarian Stimulation

Denmark, Norway, Sweden, Switzerland
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

Controlled Ovarian Simulation

Korea, Republic of, Taiwan, China, Vietnam
Nadezhda Women's Health Hospital

Completed

Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response

Poor Ovarian Reserve

Bulgaria
Ferring Pharmaceuticals

Completed

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice (DELTA)

Controlled Ovarian Stimulation

France
Nanfang Hospital of Southern Medical University
Ferring Pharmaceuticals

Unknown

Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve

Diminished Ovarian Reserve

China
Regionshospitalet Viborg, Skive

Completed

Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

OHSS (Ovarian Hyperstimulation)

Denmark
Peking University Third Hospital

Recruiting

The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR

Diminished Ovarian Reserve

China
Shi Yun
Capital Medical University

Not yet recruiting

The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)

Poor Ovarian Response

China
Generation Next Fertility
Igenomix

Not yet recruiting

Ovarian PRP for Diminished Ovarian Reserve (oPRP)

Diminished Ovarian Reserve
Beni-Suef University

Recruiting

Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials

Poor Ovarian Reserve

Egypt
Huazhong University of Science and Technology

Recruiting

Effects of Acupuncture on Ovarian Function and Pregnancy Outcomes in Women With Decreased Ovarian Reserve

Decreased Ovarian Reserve

China
Ferring Pharmaceuticals

Terminated

Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®

Controlled Ovarian Stimulation

Denmark
American University of Beirut Medical Center

Completed

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

Poor Ovarian Reserve

Lebanon
Centre Hospitalier Universitaire de Besancon
University Hospital, Rouen; CHU de Reims; Central Hospital, Nancy, France; University... and other collaborators

Unknown

Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function (DATOR)

Ovarian Function Insufficiency

France
Mỹ Đức Hospital

Completed

Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study

Poor Ovarian Response

Vietnam
Assistance Publique - Hôpitaux de Paris
Agence de La Biomédecine

Unknown

Autograft of Human Ovarian Tissue : Efficiency and Safety (CAROLéLISA)

Ovarian Tissue Transplantation

France
Kaplan Medical Center

Unknown

Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy

Ovarian Function Insufficiency

Israel
Chen Chunlin
Chinese Academy of Sciences

Recruiting

The Application of Real-Time Near-infrared Imaging in Gynecological Surgery

Cervical Cancer | Endometriosis | Uterine Sarcoma | Adenomyosis | Endometrial Carcinoma | Ovarian Tumor | Ovarian Cyst Benign | Uterine Myomatosis | Ovarian Cyst Malignant

China
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer

United States
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; The University of Queensland

Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer (IMAGE)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Australia
Gynecologic Oncology Group
National Cancer Institute (NCI); Medical Research Council; Southwest Oncology...

Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
National Cancer Institute (NCI)

Terminated

Oxaliplatin and Topotecan in Advance Ovarian Cancer

Recurrent Ovarian Epithelial Cancer

United States
Nordic Society of Gynaecological Oncology - Clinical...

Completed

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Ovarian Epithelial Cancer Recurrent

Denmark, Finland, Norway
Roswell Park Cancer Institute
Amgen

Completed

Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

Osteoporosis | Osteopenia | Allogeneic Hematopoietic Stem Cell Transplantation Recipient

United States
Asan Medical Center

Unknown

Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients (KOPIN)

Liver Transplant Recipient

Korea, Republic of
Medical University of Vienna

Recruiting

Evaluating Ovarian Reserve After Conventional Laparoscopy Versus Robotic Surgery for Bilateral Endometrioma

Ovarian Endometrioma | Ovarian Endometriosis

Austria
Shanghai First Maternity and Infant Hospital
Shanghai Tongji Hospital, Tongji University School of Medicine; International...

Recruiting

Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma

Ovarian Reserve | Ovarian Endometrioma

China
Robert Bosch Gesellschaft für Medizinische Forschung...

Completed

Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene

Anovulation | Cytochrome P450 CYP3A Enzyme Deficiency | Disorder Due Cytochrome P450 CYP2D6 Variant

Germany
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Nausea and Vomiting | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Stage IIA Fallopian Tube Cancer | Stage... and other conditions

United States
AbbVie

Withdrawn

A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer

Cancer - Ovarian
NanOlogy, LLC
US Biotest, Inc.

Terminated

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Ovarian Carcinoma

United States
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer (ICEBERG 2)

Ovarian Neoplasm

United States, Spain, Australia, Germany, Sweden
Washington University School of Medicine
Sanofi

Terminated

Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma

Ovarian Cancer

United States
UConn Health

Terminated

Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma

Ovarian Cancer

United States
Mayo Clinic

Terminated

Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand

Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)

Ovarian Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

Ovarian Neoplasm

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Gastrointestinal Complication and other conditions

United States
ARCAGY/ GINECO GROUP

Recruiting

Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer (CHRONO)

Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Ovarian Cancer Stage IIIb

France
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditions

United States
Georgetown University
United States Department of Defense; Coherus Biosciences, Inc.

Suspended

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer Stage 3

United States
Ain Shams University
Nahda University

Completed

Alendronate Versus Denosumab in Kidney Transplant Patients

Osteoporosis, Osteopenia | Renal Transplant Recipient

Egypt
shaimaa Mostafa

Completed

Right Ventricular Function in Heart Failure

Assessment of the RV Function in Patients With Heart Faliure

Clinical Trials on Incipient Ovarian Failure

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations